2021 • Positionspapier: Hinweise zur Patienteninformation und -aufklärung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) – Teil 2: Omalizumab – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
Impact:
7.0800596E-9 3.352983E-9 5 5
/ Attention: 0 17

  • Popularity:

    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.

  • Influence:

    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).

  • Citation Count:

    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).

  • Impulse:

    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.